Hangzhou AGS MedTech Co. Ltd. A Market Cap ($587.60 Million)
Market Cap & Net Worth: Hangzhou AGS MedTech Co. Ltd. A (688581)
Hangzhou AGS MedTech Co. Ltd. A market cap. Hangzhou AGS MedTech Co. Ltd. A (SHG:688581) has a market capitalization of $587.60 Million (CN¥4.02 Billion) as of November 1, 2026. Listed on the SHG stock exchange, this China-based company holds position #11029 globally and #2961 in its home market, demonstrating a -7.02% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hangzhou AGS MedTech Co. Ltd. A's stock price CN¥49.50 by its total outstanding shares 81122079 (81.12 Million). Also see Hangzhou AGS MedTech Co. Ltd. A operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Hangzhou AGS MedTech Co. Ltd. A Market Cap History (2023–2026)
Hangzhou AGS MedTech Co. Ltd. A market cap history from 2023 to 2026. Data shows change from $1.03 Billion to $587.60 Million (-14.69% CAGR). Check latest Hangzhou AGS MedTech Co. Ltd. A stock price today for real-time trading data and today's change.
Hangzhou AGS MedTech Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hangzhou AGS MedTech Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Hangzhou AGS MedTech Co. Ltd. A annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.17x
Hangzhou AGS MedTech Co. Ltd. A's market cap is 1.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.14x
Hangzhou AGS MedTech Co. Ltd. A's market cap is 3.14 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $1.03 Billion | $508.75 Million | $217.24 Million | 2.03x | 4.74x |
| 2024 | $708.56 Million | $636.63 Million | $293.39 Million | 1.11x | 2.42x |
| 2025 | $695.98 Million | $593.74 Million | $221.71 Million | 1.17x | 3.14x |
Competitor Companies of 688581 by Market Capitalization
Companies near Hangzhou AGS MedTech Co. Ltd. A in the global market cap rankings as of November 1, 2026. Also see 688581 total assets for a full breakdown of the balance sheet.
Key companies related to Hangzhou AGS MedTech Co. Ltd. A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Hangzhou AGS MedTech Co. Ltd. A (2023–2026)
Market capitalization of Hangzhou AGS MedTech Co. Ltd. A from 2023 to today. Between 2023 and today, Hangzhou AGS MedTech Co. Ltd. A's market cap moved from $1.03 Billion to $ 587.60 Million, with a yearly change of -14.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥587.60 Million | -15.57% |
| 2025 | CN¥695.98 Million | -1.78% |
| 2024 | CN¥708.56 Million | -31.23% |
| 2023 | CN¥1.03 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Hangzhou AGS MedTech Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $587.60 Million USD |
| MoneyControl | $587.60 Million USD |
| MarketWatch | $587.60 Million USD |
| marketcap.company | $587.60 Million USD |
| Reuters | $587.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hangzhou AGS MedTech Co. Ltd. A
Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; an… Read more